Aspen Aerogels Q1 revenue $45.6M (+19% YoY); net loss narrows to $16.8M; reaffirms FY23 outlook

ASPEN AEROGELS INC

2023-Q1 EPS reported -$0.24 revenue$45,586,000

Revenue $45.6M vs $38.4M YoY; net loss $16.8M ($0.24 loss per share) vs $19.5M ($0.59) prior year.
Adjusted EBITDA loss $(13.9)M vs $(14.7)M; company reiterates 2023 revenue and adjusted EBITDA guidance.
Awarded PyroThin contract for European EV commercial truck program; production start early 2024.
Executing contract manufacturing strategy to increase capacity for Energy Industrial customers in 2024.

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

ASPEN AEROGELS INC reported the first quarter of 2023 results: revenue $45.6 million, net income $16.8 million, EPS $0.24. Guidance reaffirmed.

Period: the first quarter of 2023
Revenue: $45.6 million
Net income: $16.8 million
EPS: $0.24
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Total revenue for the first quarter of 2023 was $45.6 million, compared to $38.4 million in the first quarter of last year. Net loss was $16.8 million, compared to a net loss of $19.5 million in the first quarter of last year. Net loss per share was $0.24, compared to a net loss per share of $0.59 in the first quarter last year.

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

ASPEN AEROGELS INC filing history →

Source: SEC EDGAR

accession 0000950170-23-017251

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.